메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Chung-Lin Lee (Chang Gung Memorial Hospital) Ying-Hsu Chang (Chang Gung Memorial Hospital and Chang Gung University) Chung-Yi Liu (Chang Gung Memorial Hospital and Chang Gung University) Ming-Li Hsieh (Chang Gung Memorial Hospital) Liang-Kang Huang (Chang Gung Memorial Hospital) Yuan-Cheng Chu (Chang Gung Memorial Hospital) Hung-Cheng Kan (Chang Gung Memorial Hospital) Po-Hung Lin (Chang Gung Memorial Hospital) Kai-Jie Yu (Chang Gung Memorial Hospital) Cheng-Keng Chuang (Chang Gung Memorial Hospital) Chun-Te Wu (Chang Gung Memorial Hospital) See-Tong Pang (Chang Gung Memorial Hospital) I-Hung Shao (Chang Gung Memorial Hospital)
저널정보
대한비뇨기과학회 Investigative and Clinical Urology Investigative and Clinical Urology Vol.63 No.5
발행연도
2022.9
수록면
546 - 553 (8page)
DOI
https://doi.org/10.4111/icu.20210450

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose: Metastatic castration-resistant prostate cancer (mCRPC) has a poor prognosis. Abiraterone acetate (AA), enzalutamide, and chemotherapy are first-line treatments for patients with mCRPC. This study examined prognostic factors for AA response in the form of prostate-specific antigen (PSA) kinetics throughout androgen-deprivation therapy (ADT) in chemonaive patients with mCRPC. Materials and Methods: We retrospectively included data from 34 chemonaive patients with mCRPC who had received AA at some point between January 2017 and December 2018. We separated patients into two study arms according to the decrease in PSA percentages after use of AA for 3 months. We correlated PSA kinetics parameters with response and compared the two study groups with respect to PSA kinetics. Results: The patients’ median age was 77 years. In the total group of patients, 64% had a response to AA, whereas 35% did not. The ratio of the PSA level at nadir to the level during ADT was significantly higher in the AA-sensitive group (19.78 vs. 1.03, p=0.019). Conclusions: Patients who experienced a dramatic change in PSA level during ADT were more likely to be resistant to AA after progression to mCRPC. Chemotherapy rather than AA might be more suitable as a first-line treatment for these patients.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0